PubMed Health⌕ Search

Biomedical subjects

D August

Publications and source records attributed to D August.

11 recordsLinked to original sources

Level of aggregation for optimal epidemiological analysis: the case of time to surgery and unnecessary removal of the normal appendix.

STUDY OBJECTIVE: To illustrate the concept of "individualised fallacy", the result of improper interpretation and inference about aggregate level associations on the basis of associations at the individual level, in epidemiology. DESIGN: Cohort study. SETTING: Canadian province of Ontario. PATIENTS: All patients who underwent primary appendicectomy in 175 Ontario hospitals from 1989 to 1992. The association between rate of normal appendix removal and time to surgery was analysed at two levels: (1) at individual patient level, in which, for each patient, the exact number of days to surgery was derived, and (2) at hospital level, in which hospital specific proportions of time to surgery was calculated. MAIN RESULTS: Measured at individual level, compared with patients who had an operation on the same day of admission, the odds ratio was 2.41 (95% confidence intervals 2.28, 2.56) for patients who had an operation > 1 day after admission. Measured at hospital level, each 10% increase in the proportion of patients who had an operation > 1 day after admission resulted in a 15% reduction in the odds of normal appendix removal (odds ratio 0.85, 95% confidence intervals 0.82, 0.88) CONCLUSIONS: In this case study, hospital level measure correctly predicted a reduction in the rate of normal appendix removal by delaying surgery, whereas individual level measure biased the direction of the relation to the opposite. This example illustrates that bias in across level inference can occur either at individual or ecological level. The preferred level of analysis is the one that minimises confounding; often, it must be selected on the basis of a priori knowledge of the subject area.

Adolescent↗

Immunolymphoscintigraphy in breast cancer: evaluation using 131I-labeled monoclonal antibody B72.3.

Noninvasive axillary lymph node staging was investigated using [131I]murine monoclonal antibody B72.3 in 16 patients with breast cancer scheduled for axillary dissection. [131I]B72.3 was injected into ipsilateral finger webs or around the breast biopsy. Scintigraphy to 72 h and gamma-counting/immunohistochemistry of nodes were performed. Specific antibody uptake (%ID/g) and the ratio of specific:nonspecific antibody uptake were not significantly different in tumor-positive versus tumor-negative nodes, suggesting that [131I]B72.3 is unsuitable to discriminate axillary node tumor involvement.

Antibodies, Monoclonal↗

Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience.

PURPOSE: To determine whether breast conservation and prolonged neoadjuvant chemotherapy have efficacy in locally advanced breast cancer (LABC), as measured by survival and rate of breast conservation. MATERIALS AND METHODS: Eighty-nine patients with stage III disease were enrolled at the University of Michigan (UM) onto a prospective nonrandomized trial. Patients received nine 21-day cycles of neoadjuvant chemohormonal therapy that consisted of doxorubicin 30 mg/m2 and cyclophosphamide 750 mg/m2 intravenously on day 1, conjugated estrogens 0.625 mg orally twice daily on days 6 to 8, methotrexate 40 mg/m2 and fluorouracil 500 mg/m2 intravenously on day 8, and tamoxifen 10 mg orally twice daily on days 9 to 14. Patients with a negative biopsy received radiation only, while those with residual disease underwent mastectomy and postoperative radiotherapy. Eight more cycles of chemohormonal therapy were administered after local-regional therapy. RESULTS: The clinical response rate to neoadjuvant therapy was 97%, 28% of patients had a complete pathologic response evaluated at biopsy. Five-year overall and disease-free survival probabilities were 54% and 44%, respectively. The median disease-free survival time was 2.4 years. The 5-year actuarial rates of local-regional control with local failure as only first failure were 82% and 78% following radiotherapy, and mastectomy and radiotherapy, respectively (P = .99). CONCLUSION: Prolonged neoadjuvant chemohormonal therapy and biopsy-driven local therapy have efficacy in LABC, with 28% of patients being candidates for breast conservation and a 5-year overall survival rate of 54%.

Antineoplastic Combined Chemotherapy Protocols↗

Commitment decisions: identification of indeterminate cases.

Research shows that most involuntary commitments conform to legal criteria and that psychiatrists generally agree on which patients should be committed. There are many cases, however, that cause disagreement among psychiatrists making commitment decisions. No research has been done regarding types of cases causing disagreement. The authors developed 10 clinical vignettes termed "ambiguous case constructs" that could be proven to be indeterminate and explore what underlying themes these indeterminate cases might hold in common. A pilot study was conducted to develop a set of 10 clinical vignettes, which were found to be representative of psychiatric emergencies and likely to cause discordance among evaluating psychiatrists. These validated vignettes were then presented to 62 psychiatrists who were asked to determine the commitment disposition for each vignette patient. Seven of these vignettes elicited significant disagreement among respondents and were identified as indeterminate cases. The frequency and percentage of psychiatrists endorsing commitment for each vignette is listed. This study validates the existence of indeterminate cases which prompt disagreement among psychiatrists making commitment decisions. Upon retrospective review, disagreement evoked by the seven indeterminate cases is proposed to have originated from one of four themes. The implications for clinical practice are noted.

Adult↗

Determination of zinc and copper absorption at three dietary Zn-Cu ratios by using stable isotope methods in young adult and elderly subjects.

Nine young men and six elderly men and women ingested low-zinc, low-copper, and adequate diets for 2-wk periods. The Zn-Cu ratios averaged 2:1, 15:1, and 5:1. On day 8 of each period, subjects ingested doses of 70Zn and 65Cu so that net absorption could be determined. Zn absorption on the adequate diet was 39 +/- 3% (means +/- SEM) in young subjects and 21 +/- 1% (p less than 0.05) in the elderly subjects. During the low-Zn period, Zn absorption was higher as compared with that on the adequate diet in both young (64 +/- 5%, p less than 0.05) and elderly subjects (43 +/- 7%, p less than 0.05). Cu absorption on the adequate diet was 60 +/- 4% and 53 +/- 2% in young and elderly subjects, respectively. During the low-Cu period, Cu absorption was higher as compared with that on the adequate diet in the elderly subjects (67 +/- 4%, p less than 0.05). Cu absorption was higher in six of seven young subjects on the restricted Cu diet (p greater than 0.05). The effect upon absorption of the change in the Zn-Cu ratio was less than the effect of dietary restriction.

Absorption↗

Acute dissection originating in the abdominal aorta.

A primary abdominal aortic dissection was encountered in a 53-year-old hypertensive man who was admitted with a 2-week history of back pain. Treatment with an infrarenal aortic bifurcation graft complemented by reconstruction of the proximal aortic cuff was curative.

Aortic Dissection↗

Home parenteral nutrition for patients with advanced intraperitoneal cancers and gastrointestinal dysfunction.

The use of total parenteral nutrition (TPN) in patients with advanced, untreatable cancer is controversial. Occasionally, however, damage to bowel by tumor, radiation, or surgery renders these patients unable to eat and TPN may be indicated to prevent premature death from starvation. We have used Home Parenteral Nutrition (HPN) to support three patients with advanced, untreatable abdominal cancer and inability to eat. Morbidity was minimal and survival times were 24, 6 and 1.5 months. Payment was covered by third party agencies. All patients and their families were gratified by the ability to return home with nutritional support. HPN can be used to support terminal cancer patients with bowel obstruction and may afford them longer survival. Ideally, patients considered for this should be well motivated, with good support systems, and with survival estimated to be at least months.

Abdominal Neoplasms↗

Liver transplant rejection arteritis: serial hepatic arteriography.

Two liver transplant recipients underwent serial hepatic arteriography, demonstrating a severe, rapidly progressive arteritis involving the hilar hepatic arteries. Liver biopsies in these patients demonstrated ischemic necrosis as a prominent feature. The angiographic appearance and therapeutic implications of liver transplant rejection arteritis are presented.

Arteritis↗

A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets.

To identify structures on the platelet surface which become expressed after platelet activation, we have prepared murine monoclonal antibodies specific for thrombin-activated platelets. Hybridomas were screened for clones producing antibodies which bound to thrombin-activated platelets but not to resting platelets. Clone KC4 was identified. The binding of purified I-labeled KC4 antibody, an IgG1k, to thrombin-activated platelets was saturable. Minimal binding was observed to resting platelets. The interaction of antibody with thrombin-activated platelets was characterized by a binding constant, KD, of 7.2 +/- 0.4 nM and revealed 13,400 +/- 3,000 binding sites per platelet. The presence of Ca2+ or EDTA, a pH ranging from 4 to 10, or high ionic strength had no influence on antigen-antibody interaction. The KC4 antigen was expressed on the platelet surface after activation with ADP, collagen, epinephrine, or thrombin. The extent of [14C] serotonin release during activation was directly proportional to the availability of antigen on the platelet surface regardless of agonist or platelet aggregation. The antibody is directed against a single protein which migrated between GPIIb and GPIIa after sodium dodecyl sulfate gel electrophoresis. This protein was purified from platelet membranes by immunoaffinity chromatography using KC4 antibody-agarose and demonstrated an apparent molecular weight of 140,000 in sodium dodecyl sulfate-polyacrylamide gel electrophoresis under both nonreducing and reducing conditions. Of the cells examined, only platelets contained this protein. These results indicate that platelet secretion is associated with the expression of an Mr = 140,000 integral membrane protein composed of a single polypeptide chain. This protein may be component of the internal granule membrane which is fused with the plasma membrane during activation.

Antibodies, Monoclonal↗